Metformin, a first-line biguanide, reduces hepatic glucose production, while tirzepatidea dual GIP/GLP-1 receptor agonist approved by the FDA in 2022enhances insulin secretion, suppresses glucagon, and promotes weight loss
For a pre-blended CJC + ipa combo vial (5 mg + 5 mg) reconstituted with 2 mL BAC water, you get 2,500 mcg/mL of each peptide
The key is recognizing your current abilities and building gradually
However, evidence regarding their systemic metabolic effects in children, particularly from non-Western populations, remains limited
Possible idiopathic intracranial hypertension, which has been reported rarely with GLP-1 agonists
Some practitioners also use semaglutide in combination protocols, pairing it with B12 injections, peptide stacks , or other compounds